Prediction of recurrence with the Oncotype DX recurrence score in node-positive, HR-positive, breast cancer patients treated with adjuvant chemotherapy: Results from PACS01 trial.
Frederique Madeleine Penault-Llorca
Consultant or Advisory Role - Genomic Health
Honoraria - Genomic Health
Thomas Filleron
No relevant relationships to disclose
Bernard Asselain
No relevant relationships to disclose
Frederick L. Baehner
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Pierre Fumoleau
Consultant or Advisory Role - Janssen; Novartis; Roche; Sanofi
Magali Lacroix-Triki
No relevant relationships to disclose
Steven M. Butler
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Farid Jamshidian
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Diana B. Cherbavaz
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Steven Shak
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Lise Roca
No relevant relationships to disclose
Christine Sagan
No relevant relationships to disclose
J Lemonnier
No relevant relationships to disclose
Anne-Laure Martin
No relevant relationships to disclose
Henri Hubert Roche
No relevant relationships to disclose